Difference between revisions of "LncRNAWiki:D"
Line 190: | Line 190: | ||
|DPPA2 upstream binding RNA | |DPPA2 upstream binding RNA | ||
|_ | |_ | ||
+ | |- | ||
+ | |''DLGAP4-AS1'' | ||
+ | |[[DLGAP4-AS1]] | ||
+ | |CCAT7 | ||
+ | |DLGAP4 antisense RNA 1 | ||
+ | |colorectal cancer | ||
+ | |- | ||
+ | |''DM1-AS'' | ||
+ | |[[DM1-AS]] | ||
+ | |N/A | ||
+ | |DM1 locus antisense RNA | ||
+ | |Myotonic dystrophy type 1 | ||
+ | |- | ||
+ | |''DPYD-AS2'' | ||
+ | |[[DPYD-AS2]] | ||
+ | |N/A | ||
+ | |DPYD antisense RNA 2 | ||
+ | |Cervical squamous cancers | ||
+ | |- | ||
+ | |''DSCAM-AS1'' | ||
+ | |[[DSCAM-AS1]] | ||
+ | |M41 | ||
+ | |DSCAM antisense RNA 1 | ||
+ | |breast cancer | ||
+ | |- | ||
+ | |''DSCR4'' | ||
+ | |[[DSCR4]] | ||
+ | |DCRB | ||
+ | |Down syndrome critical region 4 | ||
+ | |Down syndrome | ||
+ | |- | ||
+ | |''DSCR8'' | ||
+ | |[[DSCR8]] | ||
+ | |C21orf65, MTAG2, CT25.1a, CT25.1b, MMA-1a, MMA-1b | ||
+ | |Down syndrome critical region 8 (non-protein coding) | ||
+ | |Down syndrome, melanoma | ||
|} | |} |
Revision as of 09:12, 29 June 2017
Name | Transcript ID | Alias | Description | Disease |
---|---|---|---|---|
DACOR1 | DACOR1 | TCONSN/A00023265 | DNMT1-associated colon cancer repressed lncRNA 1 | colon cancer |
DALIR | DALIR | DALI | DNMT1-associated long intergenic non-coding RNA | _ |
DANCR | NONHSAT096369 | differentiation antagonizing non-protein coding RNA | "ANCR, AGU2, lncRNA-ANCR" | bone diseases |
DANT1 | DANT1 | N/A | "DXZ4 associated non-coding transcript 1, proximal" | _ |
DANT2 | DANT2 | N/A | "DXZ4 associated non-coding transcript 2, distal" | _ |
DAOA-AS1 | DAOA-AS1 | G30 | DAOA antisense RNA 1 | bipolar illness,schizophrenia |
DAPK1-IT1 | DAPK1-IT1 | N/A | DAPK1 intronic transcript 1 | pancreatic cancer |
DBET | NONHSAT099821 | "DBE-T, DUX4L30" | D4Z4 binding element transcript (non-protein coding) | Pancreatic ductal adenocarcinoma, Facioscapulohumeral muscular dystrophy |
DBH-AS1 | DBH-AS1 | BPR | DBH antisense RNA 1 | hepatocellular carcinoma |
DGCR10 | DGCR10 | DGS-B | DiGeorge syndrome critical region gene 10 (non-protein coding) | DiGeorge syndrome |
DGCR11 | DGCR11 | DGS-D | DiGeorge syndrome critical region gene 11 (non-protein coding) | DiGeorge and velo-cardio-facial syndrome |
DGCR12 | DGCR12 | DGS-E | DiGeorge syndrome critical region gene 12 (non-protein coding) | DiGeorge and velo-cardio-facial syndrome |
DGCR5 | DGCR5 | "NCRNA00037, LINC00037" | DiGeorge syndrome critical region gene 5 (non-protein coding) | DiGeorge syndrome |
DGCR9 | DGCR9 | "DGS-A, POM121L5P" | DiGeorge syndrome critical region gene 9 (non-protein coding) | DiGeorge syndrome |
DHFR upstream transcripts | NONHSAT102417 | "DHFR minor transcript 5'-UTR, ENSG00000228716" | N/A | _ |
DHRS4-AS1 | NONHSAT035954 | DHRS4 antisense RNA 1 | "PRO1488,AS1DHRS4" | _ |
DIAPH2-AS1 | DIAPH2-AS1 | N/A | DIAPH2 antisense RNA 1 | _ |
DIO3OS | NONHSAT040032,NONHSAT040039 | "DIO3-AS1, NCRNA00041, ""non-protein coding RNA 41"", ENSG00000258498" | DIO3 opposite strand/antisense RNA (head to head) | _ |
DISC1FP1 | DISC1FP1 | N/A | DISC1 fusion partner 1 (non-protein coding) | _ |
DISC2 | NONHSAT010191 | "DISC1-AS1, DISC1OS, NCRNA00015" | disrupted in schizophrenia 2 (non-protein coding) | affective disorders, Autism spectrum disorder, bipolar disorder, depression, schizophrenia |
DLEU1 | NONHSAT033797 | deleted in lymphocytic leukemia 1 (non-protein coding) | "LEU1, XTP6, NCRNA00021, LINC00021, BCMS1" | chronic lymphocytic leukemia |
DLEU2 | NONHSAT033821 | deleted in lymphocytic leukemia 2 (non-protein coding) | "LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG" | chronic lymphocytic leukemia, lymphocytic leukemia, myeloma |
DLG2-AS1 | DLG2-AS1 | "PSZA11q14, SZ-1" | DLG2 antisense RNA 1 | schizophrenia |
DLGAP1-AS3 | DLGAP1-AS3 | N/A | DLGAP1 antisense RNA 3 | _ |
DLX6-AS1 | DLX6-AS1 | "FLJ34048, Evf-2" | DLX6 antisense RNA 1 | _ |
DNM3OS | DNM3OS | "MIR199A2HG, DNM3-AS1" | DNM3 opposite strand/antisense RNA | Sézary syndrome |
DRAIC | DRAIC | N/A | "downregulated RNA in cancer, inhibitor of cell invasion and migration" | prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma |
DSCR10 | DSCR10 | N/A | Down syndrome critical region 10 (non-protein coding) | _ |
DSCR9 | DSCR9 | NCRNA00038 | Down syndrome critical region 9 (non-protein coding) | _ |
DUBR | DUBR | N/A | DPPA2 upstream binding RNA | _ |
DLGAP4-AS1 | DLGAP4-AS1 | CCAT7 | DLGAP4 antisense RNA 1 | colorectal cancer |
DM1-AS | DM1-AS | N/A | DM1 locus antisense RNA | Myotonic dystrophy type 1 |
DPYD-AS2 | DPYD-AS2 | N/A | DPYD antisense RNA 2 | Cervical squamous cancers |
DSCAM-AS1 | DSCAM-AS1 | M41 | DSCAM antisense RNA 1 | breast cancer |
DSCR4 | DSCR4 | DCRB | Down syndrome critical region 4 | Down syndrome |
DSCR8 | DSCR8 | C21orf65, MTAG2, CT25.1a, CT25.1b, MMA-1a, MMA-1b | Down syndrome critical region 8 (non-protein coding) | Down syndrome, melanoma |